Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences.
暂无分享,去创建一个
S. Devries | K. Chew | B. Ljung | F. Waldman | K. Kerlikowske | D. Moore | B M Ljung | D H Moore | K Kerlikowske | F M Waldman | S DeVries | K L Chew | D. Moore
[1] D Sudar,et al. Comparative Genomic Hybridization , 1995, Current protocols in human genetics.
[2] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[3] S. Martino,et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.
[4] Geoff Delaney M.B.B.S.,et al. Predictors of local recurrence after treatment of ductal carcinoma in situ - A meta-analysis , 1999 .
[5] J. Manola,et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ , 1999, Cancer.
[6] J. Boyages,et al. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. , 1999, Cancer.
[7] R E Hermann,et al. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. , 1999, Journal of the American College of Surgeons.
[8] E. Gabrielson,et al. Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[9] P. Carroll,et al. Genetic alterations in primary bladder cancers and their metastases. , 1998, Cancer research.
[10] J. Stanford,et al. Risk of recurrence after ductal carcinoma in situ of the breast. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] P. O’Connell,et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.
[12] J. Varley,et al. Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast. , 1998, British Journal of Cancer.
[13] R. Sutherland,et al. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] N. Bundred,et al. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. , 1998, British Journal of Cancer.
[15] B. Fowble. The Results of Conservative Surgery and Radiation for Mammographically Detected Ductal Carcinoma In Situ , 1997 .
[16] F. Waldman,et al. Chromosomal alterations in ulcerative colitis-related neoplastic progression. , 1997, Gastroenterology.
[17] Takafumi Nishizaki,et al. Genetic alterations in primary breast cancers and their metastases: Direct comparison using modified comparative genomic hybridization , 1997, Genes, chromosomes & cancer.
[18] O. Kallioniemi,et al. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. , 1997, The American journal of pathology.
[19] J. Varley,et al. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma , 1997, Oncogene.
[20] E A Sickles,et al. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. , 1997, Journal of the National Cancer Institute.
[21] A. Patchefsky,et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). , 1997, International journal of radiation oncology, biology, physics.
[22] E. Gabrielson,et al. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. , 1996, Cancer research.
[23] E Gabrielson,et al. Genetic divergence in the clonal evolution of breast cancer. , 1996, Cancer research.
[24] K. Kerlikowske,et al. Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.
[25] R. Brown,et al. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. , 1995, Journal of the National Cancer Institute.
[26] N. Phillips,et al. Allelic loss and the progression of breast cancer. , 1995, Cancer research.
[27] S. Hilsenbeck,et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.
[28] A. Sahin,et al. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. , 1995, Cancer research.
[29] M. Silverstein,et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. , 1995, European journal of cancer.
[30] N. Phillips,et al. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. , 1995, Cancer research.
[31] J. Warneke,et al. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. , 1995, Journal of the American College of Surgeons.
[32] M. Lagios. Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation. , 1995, Cancer letters.
[33] L. Liotta,et al. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. , 1995, Cancer research.
[34] D Rutovitz,et al. Computer image analysis of comparative genomic hybridization. , 1995, Cytometry.
[35] F. Vicini,et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. , 1995, International journal of radiation oncology, biology, physics.
[36] N. Dracopoli,et al. Current protocols in human genetics , 1994 .
[37] W. Dupont,et al. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[38] H. Oberman,et al. Tumors of the Mammary Gland , 1994 .
[39] B Fisher,et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.
[40] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .